Search Market Research Report
Nasal Swab Test Market Size, Share Global Analysis Report, , 2021 – 2026
Nasal Swab Test Market By Product Type (Non-woven, Foam-tipped Swabs, and Others), By Diagnostics Type (Molecular Diagnostics, CRISPR & Biosensors, and Others), By Mode (Point-of-Care, and Non-Point-of-Care), and By End-User (Laboratories & Diagnostics Centers, Hospitals & Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026
Industry Insights
According to the report published by the Facts and Factors, global demand for the nasal swab test market was estimated at approximately USD 108.7 Million in 2020 and is expected to generate revenue of around USD 150.7 Million by the end of 2026, growing at a CAGR of around 3.4% between 2021 and 2026.
Market Overview
The Coronavirus Disease or COVID-19 is caused by the novel coronavirus SARS-CoV-2 that is an RNA virus. Coronavirus disease can be transmitted from one person to another by means of the inhalation of infectious droplets. Some symptoms of COVID-19 comprise fatigue, dry cough, fever, and body ache. Individuals with conditions like cancer, diabetes, hypertension, old age, and others are at a high risk of getting severe COVID-19 infection. Therefore, it is necessary to expand well-organized nasal swab tests for COVID-19 diagnosis. The nasal swab tests engage the secretion collection from the inner surface of the nostril. Such samples are employed by diagnostic systems like molecular diagnostics, biosensors, immunoassays, and others. COVID-19 nasal swab tests are broadly used by clinics, hospitals, diagnostic centers, laboratories, and others.
Industry Growth Factor
The increase in the number of novel coronavirus cases is the major factor that is driving the expansion of the global nasal swab test market. Furthermore, the growing number of research and development goings-on for the improvement of the efficiency of nasal swab tests is projected to help out the global nasal swab test market during the forecast period. In accordance with the National Institutes of Health (NIH), the United States in July 2020, Helix OpCo LLC, which is a California, based population genomics company, developed standardized nasal swab kits in larger amounts for the collection of nasal secretion samples for the detection of SARS-CoV-2. This allows the processing of thousands of nasal swab samples at once and gives results in 24-48 hours. Such nasal swab kits might be shipped to healthcare systems, employers, public health departments, and others. Moreover, the increasing government funding supporting the research and development activities, which is also expected to propel the global nasal swab tests market growth during the forecast period.
On the other hand, the increase in product recalls might hamper the growth of the global nasal swab test market in the coming years. Conversely, rapid research is being performed to make low price and accurate nasal swab COVID-19 tests, which is likely to present lucrative opportunities for the market.
Segmentation Analysis
The global nasal swab test market has been segmented into product type, diagnostics type, mode, and end-user. On the basis of the type of product, the global nasal swab test market has been classified into non-woven, foam-tipped swabs, and others. Based on the type of diagnostics, the global nasal swab test market has been segmented into Molecular Diagnostics, CRISPR & Biosensors, and others. The global nasal swab test market on the basis of mode has been bifurcated into point-of-care, and non-point-of-care. In terms of the end-user industry, the global nasal swab test market has been divided into laboratories & diagnostics centers, hospitals & clinics, and others.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 108.7 Million |
Projected Market Size in 2026 |
USD 150.7 Million |
CAGR Growth Rate |
3.4% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
OraSure Technologies Inc, Abbott Laboratories, PrivaPath Diagnostics Limited, Roche Holding AG, QIAGEN N.V., Sherlock Biosciences, Becton Dickinson & Company, GenMark Diagnostics Inc., 3M Corporation, Quidel Corporation, BioMerieux SA, Fluidigm Corporation, Lucira Health, LumiraDx Ltd., Mesa Biotech Inc., Cepheid, and Siemens Healthineers AG, among others. |
Key Segment |
By Product Type, By Diagnostics Type, By Mode, By End-User, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
Geographically, the nasal swab test market has been segmented into North America, Asia-Pacific, Latin America, Europe, and the Middle East, and Africa. In terms of region, North America is anticipated to dominate the global nasal swab test market during the estimated period. The increase in the number of product launches, the growing need for diagnostic procedures, and the increasing incidence of infectious diseases are key factors that are likely to contribute significantly to the regional market upsurge. Moreover, the occurrence of top-notch research centers in addition to the rising demand for medical swabs will further assist the regional market to grow in the coming years.
The region of Asia-Pacific is projected to witness profitable growth opportunities in the forthcoming years. This can be attributed to the increase in cases of coronavirus because of the presence of high populated countries such as India, China, Japan, and others. Besides, the escalating number of coronavirus testing facilities in developing economies is expected to help the Asia-Pacific market during the forecast period.
Competitive Players
Various key players covered in the global nasal swab test market include
- OraSure Technologies Inc
- Abbott Laboratories
- PrivaPath Diagnostics Limited
- Roche Holding AG
- QIAGEN N.V.
- Sherlock Biosciences
- Becton Dickinson & Company
- GenMark Diagnostics Inc.
- 3M Corporation
- Quidel Corporation
- BioMerieux SA
- Fluidigm Corporation
- Lucira Health
- LumiraDx Ltd.
- Mesa Biotech Inc.
- Cepheid
- Siemens Healthineers AG
Moreover, the foremost companies are focusing more on marketing strategies such as collaborations, partnerships, and others, this, in turn, is anticipated to propel the growth of the global nasal swab test market.
Product Type Segment Analysis
- Non-woven
- Foam-tipped Swabs
- Others
Diagnostics Type Segment Analysis
- Molecular Diagnostics
- CRISPR & Biosensors
- Others
Mode Segment Analysis
- Point-of-Care
- Non-Point-of-Care
End-User Segment Analysis
- Laboratories & Diagnostics Centers
- Hospitals & Clinics
- Others
Regional Segment Analysis
- North America
- U.S.
- Canada
- Europe
- U.K.
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- The Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East Africa
Table of Content
Industry Major Market Players
- OraSure Technologies Inc
- Abbott Laboratories
- PrivaPath Diagnostics Limited
- Roche Holding AG
- QIAGEN N.V.
- Sherlock Biosciences
- Becton Dickinson & Company
- GenMark Diagnostics Inc.
- 3M Corporation
- Quidel Corporation
- BioMerieux SA
- Fluidigm Corporation
- Lucira Health
- LumiraDx Ltd.
- Mesa Biotech Inc.
- Cepheid
- Siemens Healthineers AG
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors